Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer
Clinical trial NCT00242567 · COMPLETED
Trial details
- NCT number
- NCT00242567
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2012-01-01
- Enrollment
- 522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.